Glucose promotes secretion-dependent renal cyst growth

The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator

(2015) Brandon Faubert et al.   CANCER LETTERS

Glucose stimulates calcium-activated chloride secretion in small intestinal cells

(2014) Liangjie Yin et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Hypoxia-Inducible Factor-1  Causes Renal Cyst Expansion through Calcium-Activated Chloride Secretion

(2013) B. Buchholz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst–forming epithelial cells

(2013) Bjoern Buchholz et al.   KIDNEY INTERNATIONAL

Advanced Glycated End-Products Affect HIF-Transcriptional Activity in Renal Cells

(2013) Tzvetanka Bondeva et al.   MOLECULAR ENDOCRINOLOGY

Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy

(2013) Isaline Rowe et al.   NATURE MEDICINE

Airway epithelial cells—Functional links between CFTR and anoctamin dependent Cl− secretion

(2012) Karl Kunzelmann et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

(2012) Vicente E. Torres et al.   NEW ENGLAND JOURNAL OF MEDICINE

High glucose and free fatty acids induce beta cell apoptosis via autocrine effects of ADP acting on the P2Y13 receptor

(2012) Chanyuan Tan et al.   Purinergic Signalling

Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease

(2011) Sara Terryn et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion

(2011) Bjoern Buchholz et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Why kidneys fail in autosomal dominant polycystic kidney disease

(2011) Jared J. Grantham et al.   Nature Reviews Nephrology

The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease

(2011) Berenice Reed et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The Raf kinase inhibitor PLX5568 slows cyst proliferation in rat polycystic kidney disease but promotes renal and hepatic fibrosis

(2011) B. Buchholz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

CFTR induces extracellular acid sensing in Xenopus oocytes which activates endogenous Ca2+-activated Cl- conductance

(2011) Patthara Kongsuphol et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis

(2011) V. Takiar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

First diabetes prevalence study in Portugal: PREVADIAB study

(2010) L. Gardete-Correia et al.   DIABETIC MEDICINE

CFTR-Adenylyl Cyclase I Association Responsible for UTP Activation of CFTR in Well-Differentiated Primary Human Bronchial Cell Cultures

(2010) Wan Namkung et al.   MOLECULAR BIOLOGY OF THE CELL

Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease

(2010) Andreas L. Serra et al.   NEW ENGLAND JOURNAL OF MEDICINE

Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease

(2010) Gerd Walz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucose metabolism parameters during an oral glucose tolerance test in patients with autosomal dominant polycystic kidney disease

(2010) Maria Pietrzak-Nowacka et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Small-Molecule CFTR Inhibitors Slow Cyst Growth in Polycystic Kidney Disease

(2008) B. Yang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

CFTR is activated through stimulation of purinergic P2Y2 receptors

(2008) Diana Faria et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Adaptation to hypoxia in the diabetic rat kidney

(2007) C. Rosenberger et al.   KIDNEY INTERNATIONAL